Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis
PR Newswire•03/11/2026•17:45 ET
0
Key Highlights
- ➤Curaleaf’s October 6 enhanced premium offer to acquire all Aurora shares remains outstanding
- ➤Aurora announced an alternative transaction from Organigram Global
- ➤Curaleaf says its offer provides greater certainty and speed to close
- ➤Curaleaf awaits Organigram transaction details, including break fee and BAT investor rights
- ➤Curaleaf says Aurora refused due diligence access and direct engagement over its offer
Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis PR Newswire
STAMFORD, Conn., Nov. 3, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis products, today acknowledges the announcement by Aurora Cannabis Inc. (TSX: ACB) (NASDAQ: ACB) ("Aurora") of an alternative transaction from Organigram Global Inc. ("Organigram").
Get started
Create a free account to read the full story.